Web-economic-crisis-health-systems-and-health-web
Web-economic-crisis-health-systems-and-health-web Web-economic-crisis-health-systems-and-health-web
Country profiles of health system responses to the crisis | Hungary 397 % Hungary: Fig. 1 Economic and fiscal indicators 2000–2007 and 2008–2011 60 55 50 45 40 35 30 25 20 15 10 5 0 −5 −10 −15 −20 −25 −30 _ _ _ _ ● ● _ _ ● ● _ _ _ ● _ Real GDP per capita growth _ _ _ _ _ ● ● _ _ ● ● ● _ _ _ Deficit/surplus (% GDP) _ _ _ _ _ _ _ _ _ _ ● ● _ _ _ ● _ ● _ ● _ _ _ _ _ Government spending (% GDP) _ _ _ _ _ ● ● ● ● ● _ _ _ _ _ Government health spending (% total government spending) _ _ _ _ _ _ ● _ ● ● ● ● _ _ _ 10−year bond rates _ _ _ _ _ _ _ ● ● ● ● ● _ _ _ _ _ Unemployment rate Notes: Deficit/surplus: Eurostat; 10-year bond rates: European Central Bank; Other indicators: WHO Health for All. Year 2000−2007 2008 2009 2010 2011 Hungary: Fig. 2 Trends in per capita spending on health, 2000–2011 Public spending per capita OOP spending per capita Non−OOP private spending per capita 900 Per capita spending $, PPP 600 300 0 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 60 Growth % 40 20 0 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 Public spending per capita growth OOP spending per capita growth Note: Spending calculated from WHO Health for All. Non−OOP private spending per capita growth
398 Economic crisis, health systems and health in Europe: country experience • SHI revenue from taxes on drug company turnover on covered products increased by more than 20%, which helped to avoid further increases in SHI contribution rates and decreased tax transfers (2012). • A new tax earmarked for health was levied on statutory car insurance premiums (2012). • Greater use of EU grants, particularly for infrastructure improvement, are expected to lead to a one-off increase in public spending on health in the years from 2013 onwards. Changes to health coverage Population (entitlement) • No response reported. The benefits package • Reduction of temporary sick leave benefits from 45 to 30 days for people without insurance and reimbursement rates from 70% (60% for people covered for less than two years) to 60% and 50%, respectively (2009). • HTA introduced for all medical technologies (previously only applied to innovative drugs) (2010). • Reduction of the maximum daily benefit from €38 to €19 and abolished payment of benefits to insurers for 30 days after losing a job (2011). • Disability pensions for people under retirement age replaced by health insurance benefits either in the form of rehabilitation benefit or of disability benefit (2012). User charges • User charges abolished for GP visits, dentist visits, outpatient visits, outpatient rehabilitation, not having the correct paperwork in outpatient care (if admittance letter is needed), inappropriate use of inpatient beds and inpatient daily charge (2008). Changes to health service planning, purchasing and delivery Prices of medical goods • Introduction of new rewards for pharmacies switching to therapeutically equivalent substitutes (2011). • Introduction of new financial incentives to reward doctors for prescribing cheaper substitutes (therapeutically equivalent) (2010). • Introduction of a blind bidding system for reference pricing (2011); products with bids 5% more expensive are penalized with a 15% lower reimbursement rate.
- Page 380 and 381: Country profiles of health system r
- Page 382 and 383: Bulgaria Antoniya Dimova and Mina P
- Page 384 and 385: Country profiles of health system r
- Page 386 and 387: Country profiles of health system r
- Page 388 and 389: Country profiles of health system r
- Page 390 and 391: Cyprus Elisavet Constantinou and Ma
- Page 392 and 393: Country profiles of health system r
- Page 394 and 395: Czech Republic Tomáš Roubal and J
- Page 396 and 397: Country profiles of health system r
- Page 398 and 399: Country profiles of health system r
- Page 400 and 401: Country profiles of health system r
- Page 402 and 403: Country profiles of health system r
- Page 404 and 405: Estonia Triin Habicht and Mall Lein
- Page 406 and 407: Country profiles of health system r
- Page 408 and 409: Finland Jan Klavus and Lauri Vuoren
- Page 410 and 411: Country profiles of health system r
- Page 412 and 413: France Karine Chevreul, Karen Berg
- Page 414 and 415: Country profiles of health system r
- Page 416 and 417: Country profiles of health system r
- Page 418 and 419: Country profiles of health system r
- Page 420 and 421: Germany Klaus-Dirk Henke and Wilm Q
- Page 422 and 423: Country profiles of health system r
- Page 424 and 425: Country profiles of health system r
- Page 426 and 427: Country profiles of health system r
- Page 428 and 429: Country profiles of health system r
- Page 432 and 433: Country profiles of health system r
- Page 434 and 435: Iceland Sigrún Gunnarsdóttir and
- Page 436 and 437: Country profiles of health system r
- Page 438 and 439: Ireland Anne Nolan and Steve Thomas
- Page 440 and 441: Country profiles of health system r
- Page 442 and 443: Country profiles of health system r
- Page 444 and 445: Israel Bruce Rosen and Amir Shmueli
- Page 446 and 447: Country profiles of health system r
- Page 448 and 449: Country profiles of health system r
- Page 450 and 451: Country profiles of health system r
- Page 452 and 453: Kazakhstan Ninel Kadyrova and Tata
- Page 454 and 455: Country profiles of health system r
- Page 456 and 457: Country profiles of health system r
- Page 458 and 459: Latvia Uldis Mitenbergs and Maris T
- Page 460 and 461: Country profiles of health system r
- Page 462 and 463: Country profiles of health system r
- Page 464 and 465: Country profiles of health system r
- Page 466 and 467: Country profiles of health system r
- Page 468 and 469: Country profiles of health system r
- Page 470 and 471: Malta Natasha Azzopardi Muscat Econ
- Page 472 and 473: Country profiles of health system r
- Page 474 and 475: Country profiles of health system r
- Page 476 and 477: Country profiles of health system r
- Page 478 and 479: Montenegro Ratka Knežević Economi
Country profiles of <strong>health</strong> system responses to the <strong>crisis</strong> | Hungary<br />
397<br />
%<br />
Hungary: Fig. 1 Economic <strong>and</strong> fiscal indicators 2000–2007 <strong>and</strong> 2008–2011<br />
60<br />
55<br />
50<br />
45<br />
40<br />
35<br />
30<br />
25<br />
20<br />
15<br />
10<br />
5<br />
0<br />
−5<br />
−10<br />
−15<br />
−20<br />
−25<br />
−30<br />
_ _<br />
_ _<br />
● ●<br />
_ _<br />
●<br />
●<br />
_ _<br />
_<br />
●<br />
_<br />
Real GDP<br />
per capita growth<br />
_ _<br />
_ _ _<br />
● ●<br />
_ _<br />
●<br />
● ●<br />
_ _ _<br />
Deficit/surplus<br />
(% GDP)<br />
_ _ _ _ _ _ _ _<br />
_ _<br />
●<br />
●<br />
_ _<br />
_<br />
● _ ●<br />
_<br />
●<br />
_ _ _ _ _<br />
Government<br />
spending<br />
(% GDP)<br />
_ _ _ _ _<br />
● ● ● ● ●<br />
_ _ _ _ _<br />
Government<br />
<strong>health</strong> spending<br />
(% total government<br />
spending)<br />
_ _ _ _ _<br />
_ ● _ ●<br />
●<br />
●<br />
●<br />
_ _ _<br />
10−year<br />
bond rates<br />
_ _ _ _ _<br />
_ _<br />
●<br />
●<br />
●<br />
●<br />
●<br />
_ _ _ _ _<br />
Unemployment<br />
rate<br />
Notes: Deficit/surplus: Eurostat; 10-year bond rates: European Central Bank; Other indicators:<br />
WHO Health for All.<br />
Year<br />
2000−2007 2008 2009 2010 2011<br />
Hungary: Fig. 2 Trends in per capita spending on <strong>health</strong>, 2000–2011<br />
Public spending per capita OOP spending per capita Non−OOP private spending per capita<br />
900<br />
Per capita spending $, PPP<br />
600<br />
300<br />
0<br />
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011<br />
60<br />
Growth %<br />
40<br />
20<br />
0<br />
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011<br />
Public spending<br />
per capita growth<br />
OOP spending<br />
per capita growth<br />
Note: Spending calculated from WHO Health for All.<br />
Non−OOP private spending<br />
per capita growth
Change language